Solid Biosciences (SLDB) Depreciation and Depletion (2017 - 2023)

Solid Biosciences (SLDB) has 7 years of Depreciation and Depletion data on file, last reported at $587000.0 in Q4 2023.

• For the quarter ending Q4 2023, Depreciation and Depletion rose 8.91% year-over-year to $587000.0; the trailing twelve-month figure through Dec 2023 stood at $2.6 million (up 7.18% YoY), and the FY2023 full-year result was $2.6 million, up 7.18% from the prior year.
• Depreciation and Depletion held at $587000.0 in Q4 2023, from $588000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $1.3 million in Q2 2020 to a low of $438000.0 in Q3 2022.
• A 5-year average of $734950.0 and a median of $720000.0 in 2021 frame the typical range for Depreciation and Depletion.
• Across the five-year window, Depreciation and Depletion soared 162.56% in 2019 and sank 46.18% in 2021, its largest moves.
• Tracing SLDB's Depreciation and Depletion over 5 years: stood at $806000.0 in 2019, then retreated by 1.24% to $796000.0 in 2020, then decreased by 4.52% to $760000.0 in 2021, then retreated by 29.08% to $539000.0 in 2022, then grew by 8.91% to $587000.0 in 2023.
• Business Quant data shows SLDB's Depreciation and Depletion at $587000.0 in Q4 2023, $588000.0 in Q3 2023, and $703000.0 in Q2 2023.